Pressure ulcer is a localized injury of the skin and/or underlying tissue resulting from an external mechanical load by the body, applied to soft biological tissues. Body pressure has been recognized as the most important extrinsic factor involved in the development of pressure ulcers. Pressure ulcer can be classified as non-blanchable erythema (stage I), abrasion or a blister (stage II), superficial ulcer (stage III) and deep ulcer (Stage IV).
The global pressure relief devices market is estimated to account for US$ 4,078.1 Mn in terms of value by the end of 2027.
Global Pressure Relief Devices Market: Drivers
Increasing prevalence of obesity is expected to propel growth of the global pressure relief devices market over the forecast period. For instance, according to the Centers of Disease Control and Prevention, Behavioral Risk Factor Surveillance System, 2018, 71424.3 thousand people in the U.S. suffer from obesity.
Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.
North America held dominant position in the global pressure relief devices market in 2019, accounting for 49.0% share in terms of value, followed by Europe and Asia Pacific, respectively
Figure 1: Global Pressure Relief Devices Market Share (%) Value, By Region, 2019
Global Pressure Relief Devices Market: Restraints
High cost of pressure ulcer treatment is expected to propel growth of the market. For instance, the cost of treating a single full-thickness pressure ulcer/injury can be around US$ 70,000 in the U.S.
Moreover, unfavorable reimbursement policies also limit the market growth. Changes in reimbursement policies have played a crucial role in the pressure relief devices industry in the past few years. Pressure ulcer is a very expensive disease and requires large amount of money for treatment and monitoring. High cost of pressure relief devices creates uncertainty among buyers. Hence, reimbursement is considered an essential aspect of the treatment. The Centers for Medicare and Medicaid Services (CMS) published in 2009 that it would not provide reimbursement for hospital-acquired stage III and IV pressure ulcer. Moreover, private insurers are adopting these reimbursement restrictions for pressure ulcer treatment. This factor is more prominent in developing nations such as India, China, Brazil, and Mexico due to low affordability to purchase highly expensive brand new pressure relief devices.
Global Pressure Relief Devices Market: Opportunities
High prevalence of pressure ulcers in emerging economies is expected to offer lucrative growth opportunities for players in the global pressure relief devices market. For instance, according to a cross?sectional study of older adults in Indonesia, conducted by Maastricht University, The Netherlands, and published in the International Wound Journal in April 2019, the prevalence of pressure ulcers excluding category 1 were 10.8% and 5.2% for category 2 and category 3, respectively.
Moreover, very few therapies in the market have demonstrated clear benefit over the others in the treatment of pressure ulcers. Market players can focus on developing advanced pressure relief devices to address the issue.
The global pressure relief devices market was valued at US$ 2,694.8 Mn in 2019 and is forecast to reach a value of US$ 4,078.1 Mn by 2027 at a CAGR of 5.2% between 2020 and 2027.
Figure 2: Global Pressure Relief Devices Market Value (US$ Bn), 2016 – 2027
Market Trends/Key Takeaways
The incidence of pressure ulcers is high in patients with cancer. For instance, according to the study ‘Pressure Ulcer Prevalence, Incidence, Risk, Clinical Features, and Outcomes Among Patients in a Turkish Hospital: A Cross-sectional, Retrospective Study’, published in the journal Wound Management & Prevention, in February 2019, 56% of pressure ulcer patients were oncology patients, followed by dementia/Alzheimer's patients.
The market is witnessing launch of grafts for the treatment of pressure ulcers. For instance, in February 2020, RedDress, a privately held, Israel and U.S. based company, launched ActiGraft, the first wound treatment that transforms a patient's blood into an autologous whole blood clot tissue in real time, in the U.S. It can be used in the treatment of diabetic/neuropathic ulcers, pressure ulcers/injury, and venous stasis ulcers.
Global Pressure Relief Devices Market: Competitive Landscape
Major players operating in the global pressure relief device market include, ArjoHuntleigh, Medtronic Plc, Hill-Rom Holdings, Inc., Invacare Corporation, Smith & Nephew Plc, Stryker Corporation, Talley Group Limited, and Paramount Bed Holdings Co., Ltd.
Global Pressure Relief Devices Market: Key Developments
Major players in the market are focused on increasing their production capacity during the Covid-19 pandemic. For instance, in March 2020, Hill-Rom Holdings, Inc. announced that the company is focused on doubling the production of critical care products.
Major players in the market are also focused on expanding their production facilities. For instance, in February 2020, Smith+Nephew announced the start of construction of its new high technology manufacturing facility located in Batu Kawan Industrial Park in Penang, Malaysia.
Pressure relief devices are used to prevent pressure ulcers as well as to support the treatment for pressure ulcers for bedridden patients. Pressure ulcers develop at various bony sites on the body such as back, hip, shoulder blades, lower back tailbone, heels, ankles, and skin behind the knees. Major factors driving growth of the pressure relief devices market is increasing prevalence of pressure ulcers, and increasing prevalence of obesity. Moreover, increasing prevalence of cancer is also expected assist the market growth during the forecast period.
Key features of the study: